logo
Flotek Announces Second Quarter 2025 Earnings Release and Conference Call Schedule

Flotek Announces Second Quarter 2025 Earnings Release and Conference Call Schedule

Yahoo23-06-2025
HOUSTON, June 23, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced the Company's schedule for releasing its second quarter 2025 financial and operating results.
The Company plans to issue its second quarter 2025 financial and operating results press release after market close on Tuesday, August 5, 2025, and will host its earnings conference call on Wednesday, August 6, 2025, at 9:00 a.m. Central (10:00 a.m. Eastern). The press release will be posted on the Company's website at https://ir.flotekind.com/press-releases.
Participants may access the call through Flotek's website at https://ir.flotekind.com/events, by telephone toll free at 1-800-836-8184 (international toll: 1-646-357-8785), or by using the following link to access the webcast: https://app.webinar.net/NLao0z9kmlg approximately five minutes prior to the start of the call. Following the conclusion of the conference call, a recording of the call will be available on the Company's website.
About Flotek Industries, Inc.
Flotek Industries, Inc. is a leading chemistry and data technology company focused on servicing the Energy industry. The Company's top tier technologies leverage near real-time data to deliver innovative solutions to maximize customer returns. Flotek has an intellectual property portfolio of over 130 patents, 20+ years of field and laboratory data, and a global presence in more than 59 countries.
Flotek has established collaborative partnerships focused on sustainable and optimized chemistry and data solutions, aiming to reduce the environmental impact of energy on land, air, water and people.
Flotek is based in Houston, Texas and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK." For additional information, please visit www.flotekind.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/flotek-announces-second-quarter-2025-earnings-release-and-conference-call-schedule-302488643.html
SOURCE Flotek Industries, Inc.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pfizer (PFE) Reports Earnings Tomorrow: What To Expect
Pfizer (PFE) Reports Earnings Tomorrow: What To Expect

Yahoo

timean hour ago

  • Yahoo

Pfizer (PFE) Reports Earnings Tomorrow: What To Expect

Global pharmaceutical company Pfizer (NYSE:PFE) will be announcing earnings results this Tuesday before market open. Here's what to look for. Pfizer missed analysts' revenue expectations by 1.6% last quarter, reporting revenues of $13.72 billion, down 7.8% year on year. It was a mixed quarter for the company, with a solid beat of analysts' organic revenue estimates but a miss of analysts' full-year EPS guidance estimates. Is Pfizer a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Pfizer's revenue to grow 2.2% year on year to $13.58 billion, in line with the 2.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.57 per share. Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 6 downward revisions over the last 30 days (we track 11 analysts). Pfizer has missed Wall Street's revenue estimates three times over the last two years. Looking at Pfizer's peers in the branded pharmaceuticals segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Bristol-Myers Squibb posted flat year-on-year revenue, beating analysts' expectations by 7.8%, and Merck reported a revenue decline of 1.9%, falling short of estimates by 1.1%. Bristol-Myers Squibb traded down 3.9% following the results while Merck was also down 2.7%. Read our full analysis of Bristol-Myers Squibb's results here and Merck's results here. Debates around the economy's health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the branded pharmaceuticals stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. Pfizer is down 6.8% during the same time and is heading into earnings with an average analyst price target of $28.67 (compared to the current share price of $23.53). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Earnings To Watch: Alight (ALIT) Reports Q2 Results Tomorrow
Earnings To Watch: Alight (ALIT) Reports Q2 Results Tomorrow

Yahoo

timean hour ago

  • Yahoo

Earnings To Watch: Alight (ALIT) Reports Q2 Results Tomorrow

Human capital management provider Alight (NYSE:ALIT) will be reporting earnings this Tuesday morning. Here's what investors should know. Alight beat analysts' revenue expectations by 1.2% last quarter, reporting revenues of $548 million, down 2% year on year. It was a strong quarter for the company, with an impressive beat of analysts' EPS guidance for next quarter estimates and full-year revenue guidance meeting analysts' expectations. Is Alight a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Alight's revenue to decline 2.4% year on year to $525 million, improving from the 4.1% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.10 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Alight has missed Wall Street's revenue estimates five times over the last two years. Looking at Alight's peers in the professional staffing & hr solutions segment, some have already reported their Q2 results, giving us a hint as to what we can expect. ManpowerGroup posted flat year-on-year revenue, beating analysts' expectations by 3.6%, and Robert Half reported a revenue decline of 7%, topping estimates by 1.1%. ManpowerGroup's stock price was unchanged after the resultswhile Robert Half was down 6.1%. Read our full analysis of ManpowerGroup's results here and Robert Half's results here. Debates around the economy's health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the professional staffing & hr solutions stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.4% on average over the last month. Alight is down 14% during the same time and is heading into earnings with an average analyst price target of $9.57 (compared to the current share price of $5.10). Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Earnings To Watch: RingCentral (RNG) Reports Q2 Results Tomorrow
Earnings To Watch: RingCentral (RNG) Reports Q2 Results Tomorrow

Yahoo

timean hour ago

  • Yahoo

Earnings To Watch: RingCentral (RNG) Reports Q2 Results Tomorrow

Office and call centre communications software provider RingCentral (NYSE:RNG) will be reporting results this Tuesday afternoon. Here's what investors should know. RingCentral met analysts' revenue expectations last quarter, reporting revenues of $612.1 million, up 4.8% year on year. It was a mixed quarter for the company, with a decent beat of analysts' EBITDA estimates but a miss of analysts' billings estimates. Is RingCentral a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting RingCentral's revenue to grow 4.2% year on year to $617.7 million, slowing from the 9.9% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.02 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. RingCentral has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 0.6% on average. Looking at RingCentral's peers in the productivity software segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Five9 delivered year-on-year revenue growth of 12.4%, beating analysts' expectations by 2.9%, and ServiceNow reported revenues up 22.4%, topping estimates by 2.9%. Five9 traded down 6.1% following the results while ServiceNow was up 4.3%. Read our full analysis of Five9's results here and ServiceNow's results here. The outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. While some of the productivity software stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 5% on average over the last month. RingCentral is down 19.7% during the same time and is heading into earnings with an average analyst price target of $33.29 (compared to the current share price of $23.75). Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store